Summary of Study ST002444

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001575. The data can be accessed directly via it's Project DOI: 10.21228/M83X51 This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Study ID	ST002444
Study Title	Zebrafish Optic Nerve Regeneration Metabolomics - 3 Days Post Crush
Study Summary	Zebrafish (Danio Rerio) have the capacity for successful adult optic nerve regeneration. In contrast, mammals lack this intrinsic ability and undergo irreversible neurodegeneration seen in glaucoma and other optic neuropathies. Optic nerve regeneration is often studied using optic nerve crush, a mechanical neurodegenerative model. Untargeted metabolomic studies within successful regenerative models are deficient. Evaluation of tissue metabolomic changes in active zebrafish optic nerve regeneration can elucidate prioritized metabolite pathways that can be targeted in mammalian systems for therapeutic development. Female and male (6 month to 1 year old) right Zebrafish (Tg(gap43:GFP)) optic nerves were crushed and collected three days after. Contralateral, uninjured optic nerves were collected as controls. The tissue was dissected from euthanized fish and frozen on dry ice. Samples were pooled for each category (female crush, female control, male crush, male control) and pooled at n = 31 to obtain sufficient metabolite concentrations for analysis. Optic nerve regeneration was verified by microscope visualization of GFP fluorescence. Metabolites were extracted using a Precellys Homogenizer and a serial extraction method: (1) 1:1 Methanol/Water and (2) 8:1:1 Acetonitrile/Methanol/Acetone. Metabolites were analyzed by untargeted liquid chromatography-mass spectrometry (LC MS-MS) profiling using a Q-Exactive Orbitrap instrument coupled with Vanquish Horizon Binary UHPLC LC-MS system. Metabolites were identified and quantified using Compound Discoverer 3.3 and isotopic internal metabolites standards.
Institute	University of Miami
Department	McKnight - Ophthalmology
Laboratory	Bhattacharya Lab
Last Name	Bhattacharya
First Name	Sanjoy
Address	1638 NW 10th Avenue, Room 706-A, Miami, FL 33136
Email	sbhattacharya@med.miami.edu
Phone	3054824103
Submit Date	2022-12-19
Num Groups	2
Total Subjects	67
Num Males	36
Num Females	31
Raw Data Available	Yes
Raw Data File Type(s)	mzML
Analysis Type Detail	LC-MS
Release Date	2023-01-25
Release Version	1

Select appropriate tab below to view additional metadata details:

Project:

Project ID:	PR001575
Project DOI:	doi: 10.21228/M83X51
Project Title:	Regenerative Metabolomic Profiles of the Zebrafish Visual System
Project Summary:	Zebrafish (Danio Rerio) have the capacity for successful adult optic nerve regeneration. In contrast, mammals lack this intrinsic ability and undergo irreversible neurodegeneration seen in glaucoma and other optic neuropathies. Optic nerve regeneration is often studied using optic nerve crush, a mechanical neurodegenerative model. Currently, untargeted metabolomic studies within successful regenerative models are deficient. Evaluation of tissue metabolomic changes in active zebrafish optic nerve regeneration can elucidate prioritized metabolite pathways to be targeted in mammalian systems for therapeutic development. Female and male (6 month to 1 year old) right Zebrafish (Tg(gap43:GFP)) optic nerves were crushed and collected three days after. The associated retinas and tecta were also collected under the same conditions for metabolic analysis. Contralateral, uninjured optic nerves, retinas and tecta were collected as controls. The three tissue types (optic nerve, retina, and tectum) were dissected from euthanized fish and frozen on dry ice. Optic nerve samples were pooled for each category (female crush, female control, male crush, male control) and pooled at n = 31 to obtain sufficient metabolite concentrations for analysis. Retina and tectum samples were pooled using the same categories (female crush, female control, male crush, male control) at n = 10-12. Regeneration was verified by microscope visualization of GFP fluorescence. Metabolites were extracted using a Precellys Homogenizer and a serial extraction method: (1) 1:1 Methanol/Water and (2) 8:1:1 Acetonitrile/Methanol/Acetone. Metabolites were analyzed by untargeted liquid chromatography-mass spectrometry (LC MS-MS) profiling using a Q-Exactive Orbitrap instrument coupled with Vanquish Horizon Binary UHPLC LC-MS system. Metabolites were identified and quantified using Compound Discoverer 3.3 and isotopic internal metabolite standards.
Institute:	University of Miami
Department:	McKnight - Ophthalmology
Laboratory:	Bhattacharya Lab
Last Name:	Bhattacharya
First Name:	Sanjoy
Address:	1638 NW 10th Avenue, Room 706-A, Miami, FL 33136
Email:	sbhattacharya@med.miami.edu
Phone:	3054824103

Subject:

Subject ID:	SU002533
Subject Type:	Fish
Subject Species:	Danio rerio
Taxonomy ID:	7955
Gender:	Male and female

Factors:

Subject type: Fish; Subject species: Danio rerio (Factor headings shown in green)

mb_sample_id	local_sample_id	Gender	Treatment
SA244574	Right_Optic_Nerve_1_2_POS	Female	Injured
SA244575	Right_Optic_Nerve_1_3_NEG	Female	Injured
SA244576	Right_Optic_Nerve_1_1_POS	Female	Injured
SA244577	Right_Optic_Nerve_1_3_POS	Female	Injured
SA244578	Right_Optic_Nerve_1_1_NEG	Female	Injured
SA244579	Right_Optic_Nerve_1_2_NEG	Female	Injured
SA244580	Left_Optic_Nerve_1_2_NEG	Female	Uninjured
SA244581	Left_Optic_Nerve_1_3_NEG	Female	Uninjured
SA244582	Left_Optic_Nerve_1_1_NEG	Female	Uninjured
SA244583	Left_Optic_Nerve_1_3_POS	Female	Uninjured
SA244584	Left_Optic_Nerve_1_2_POS	Female	Uninjured
SA244585	Left_Optic_Nerve_1_1_POS	Female	Uninjured
SA244586	Right_Optic_Nerve_2_2_NEG	Male	Injured
SA244587	Right_Optic_Nerve_2_3_NEG	Male	Injured
SA244588	Right_Optic_Nerve_2_1_NEG	Male	Injured
SA244589	Right_Optic_Nerve_2_3_POS	Male	Injured
SA244590	Right_Optic_Nerve_2_2_POS	Male	Injured
SA244591	Right_Optic_Nerve_2_1_POS	Male	Injured
SA244592	Left_Optic_Nerve_2_3_NEG	Male	Uninjured
SA244593	Left_Optic_Nerve_2_2_POS	Male	Uninjured
SA244594	Left_Optic_Nerve_2_1_POS	Male	Uninjured
SA244595	Left_Optic_Nerve_2_3_POS_20221118115945	Male	Uninjured
SA244596	Left_Optic_Nerve_2_2_NEG	Male	Uninjured
SA244597	Left_Optic_Nerve_2_1_NEG	Male	Uninjured
SA244598	System_Suitability_Blank_NEG_20221119033833	N/A	N/A
SA244599	Pooled_QC2_ON_NEG	N/A	N/A
SA244600	Pooled_QC_MS2_2_ON_NEG	N/A	N/A
SA244601	System_Suitability_Blank_NEG	N/A	N/A
SA244602	Pooled_QC_MS2_1_ON_POS	N/A	N/A
SA244603	Pooled_QC2_ON_POS	N/A	N/A
SA244604	Pooled_QC1_ON_POS	N/A	N/A
SA244605	System_Suitability_Blank_POS_20221118022039	N/A	N/A
SA244606	Extraction_Blank_1_POS	N/A	N/A
SA244607	Pooled_QC_MS2_2_ON_POS	N/A	N/A
SA244608	System_Suitability_Blank_POS_20221118065605	N/A	N/A
SA244609	System_Suitability_Blank_NEG_20221118230351	N/A	N/A
SA244610	Pooled_QC1_ON_NEG	N/A	N/A
SA244611	System_Suitability_Blank_NEG_20221118182825	N/A	N/A
SA244612	Extraction_Blank_1_NEG	N/A	N/A
SA244613	System_Suitability_Blank_POS	N/A	N/A
SA244614	Pooled_QC_MS2_1_ON_NEG	N/A	N/A

Showing results 1 to 41 of 41

Showing results 1 to 41 of 41

Collection:

Collection ID:	CO002526
Collection Summary:	For tissue collection, animals were euthanized by overdose of MS-222 and optic nerve removed by dissection from the optic nerve head to the optic chiasm. Female and male Zebrafish optic nerves were collected separated and are separate biological samples. Due to the small tissue and metabolomics resolution constraints, optic nerves were pooled to generate higher signal intensities. 31 and 36 crushed optic nerves were pooled for female and male zebrafish samples, respectively. The contralateral uncrushed optic nerves were pooled in the same way.
Sample Type:	Eye tissue

Treatment:

Treatment ID:	TR002545
Treatment Summary:	For optic nerve crush, animals were deeply anesthetized in 0.033% tricaine methane-sulfonate (MS-222). The right optic nerve was exposed by gently removing the connective tissue on the dorsal half of the eye and rotating the eye ventrally out of the orbit with a number 5 forceps. A nerve crush was then performed using number 5 forceps to crush the nerve ~0.5–1 mm from the optic nerve head for 5 s. Success was observed by the generation of a translucent stripe in the nerve that completely separated two areas of white myelination with no bleeding. Fish were then revived in fresh aquatic system water in individual tanks. After 1 h the tanks were returned to the fish system and animals were maintained normally with daily feeding until 3 days post injury.

Treatment ID:

TR002545

Treatment Summary:

For optic nerve crush, animals were deeply anesthetized in 0.033% tricaine methane-sulfonate (MS-222). The right optic nerve was exposed by gently removing the connective tissue on the dorsal half of the eye and rotating the eye ventrally out of the orbit with a number 5 forceps. A nerve crush was then performed using number 5 forceps to crush the nerve ~0.5–1 mm from the optic nerve head for 5 s. Success was observed by the generation of a translucent stripe in the nerve that completely separated two areas of white myelination with no bleeding. Fish were then revived in fresh aquatic system water in individual tanks. After 1 h the tanks were returned to the fish system and animals were maintained normally with daily feeding until 3 days post injury.

Sample Preparation:

Sampleprep ID:	SP002539
Sampleprep Summary:	Metabolite extraction from samples was carried out quickly while keeping optic nerve tissues on dry ice to prevent metabolite degradation. Tissues were transferred to 0.5mL Soft Tissue Lysing Kit Precellys tubes containing beads. Add 84 µL of chilled 1:1 MeOH/H2O to Precellys tube. Pre-extraction internal standards were added to the tubes. Add pre-extraction internal standards: 5µl of 1mg/ml Caffeine 13C6, 5µl of 1mg/ml D-Glucose 13C6, 5µl of 1mg/ml Oleic Acid 13C5, and 1µl of 5mg/mL Isoleucine 13C6 to each sample. Tissues were homogenized using Precellys 24 Touch. Cycle parameters: 2 cycles: 30 seconds homogenization at 4500 rpm, 10 seconds rest. Transfer homogenate to microcentrifuge tube and centrifuge at 18000xrcf for 20 min at 4°C. Collect supernatant and transfer pellet to Precellys Lysing Kit tube. Add 84uL of 8:1:1 Acetonitrile/Methanol/Acetone to pellet and add the rest of the pre-extraction internal standards: 5µl of 1mg/ml Caffeine 13C6, 5µl of 1mg/ml D-Glucose 13C6, 5µl of 1mg/ml Oleic Acid 13C5, 1µl of 5mg/mL Isoleucine 13C6. Final pre-extraction internal standards concentrations are 50μg/mL. Homogenization cycles were repeating using Precellys 24 Touch. Centrifuge as before and add second supernatant to first round of collected supernatant. Centrifuge at 1800xrcf for 20 min once more to remove any remaining tissue debris. Collect supernatant and dry supernatant in Speedvac. Two extraction blanks were prepared in the same manner as the biological samples. Dried samples were reconstituted immediately in 0.1% formic acid in 44.75µL of HPLC-MS grade water. Post-extraction internal standards were added: 25 µl of 5mg/ml Phenylalanine 13C6, 2.5 µl of .5mg/ml Uracil 13C 15N2, 1.25 µl of 1mg/ml Arginine 13C6, 1.25 µl of 1mg/ml Serine 13C3 to each sample.

Sampleprep ID:

SP002539

Sampleprep Summary:

Metabolite extraction from samples was carried out quickly while keeping optic nerve tissues on dry ice to prevent metabolite degradation. Tissues were transferred to 0.5mL Soft Tissue Lysing Kit Precellys tubes containing beads. Add 84 µL of chilled 1:1 MeOH/H2O to Precellys tube. Pre-extraction internal standards were added to the tubes. Add pre-extraction internal standards: 5µl of 1mg/ml Caffeine 13C6, 5µl of 1mg/ml D-Glucose 13C6, 5µl of 1mg/ml Oleic Acid 13C5, and 1µl of 5mg/mL Isoleucine 13C6 to each sample. Tissues were homogenized using Precellys 24 Touch. Cycle parameters: 2 cycles: 30 seconds homogenization at 4500 rpm, 10 seconds rest. Transfer homogenate to microcentrifuge tube and centrifuge at 18000xrcf for 20 min at 4°C. Collect supernatant and transfer pellet to Precellys Lysing Kit tube. Add 84uL of 8:1:1 Acetonitrile/Methanol/Acetone to pellet and add the rest of the pre-extraction internal standards: 5µl of 1mg/ml Caffeine 13C6, 5µl of 1mg/ml D-Glucose 13C6, 5µl of 1mg/ml Oleic Acid 13C5, 1µl of 5mg/mL Isoleucine 13C6. Final pre-extraction internal standards concentrations are 50μg/mL. Homogenization cycles were repeating using Precellys 24 Touch. Centrifuge as before and add second supernatant to first round of collected supernatant. Centrifuge at 1800xrcf for 20 min once more to remove any remaining tissue debris. Collect supernatant and dry supernatant in Speedvac. Two extraction blanks were prepared in the same manner as the biological samples. Dried samples were reconstituted immediately in 0.1% formic acid in 44.75µL of HPLC-MS grade water. Post-extraction internal standards were added: 25 µl of 5mg/ml Phenylalanine 13C6, 2.5 µl of .5mg/ml Uracil 13C 15N2, 1.25 µl of 1mg/ml Arginine 13C6, 1.25 µl of 1mg/ml Serine 13C3 to each sample.

Combined analysis:

Analysis ID	AN003981	AN003982
Analysis type	MS	MS
Chromatography type	HILIC	HILIC
Chromatography system	Thermo Vanquish	Thermo Vanquish
Column	Thermo Accucore Amide HILIC (150 x 2.1mm, 2.6um)	Thermo Accucore Amide HILIC (150 x 2.1mm, 2.6um)
MS Type	ESI	ESI
MS instrument type	Orbitrap	Orbitrap
MS instrument name	Thermo Q Exactive Orbitrap	Thermo Q Exactive Orbitrap
Ion Mode	POSITIVE	NEGATIVE
Units	normalized peak areas	normalized peak areas

Chromatography:

Chromatography ID:	CH002944
Chromatography Summary:	Mobile Phases: NEG A: 10mM Ammonium Acetate in 95% ACN w/ .1% acetic acid NEG B: 10mM Ammonium Acetate in 50% ACN w/ .1% acetic acid POS A: 10mM Ammonium Formate in 95% ACN w/ .1% formic acid POS B: 10mM Ammonium Formate in 50% ACN w/ .1% formic acid
Instrument Name:	Thermo Vanquish
Column Name:	Thermo Accucore Amide HILIC (150 x 2.1mm, 2.6um)
Column Temperature:	35 C
Flow Gradient:	PumpModule.Pump.Pump_Pressure.AcqOn 0.000 [min] Run PumpModule.Pump.Flow.Nominal: 0.500 [ml/min] PumpModule.Pump.%B.Value: 1.0 [%] PumpModule.Pump.Curve: 5 1.000 [min] PumpModule.Pump.Flow.Nominal: 0.500 [ml/min] PumpModule.Pump.%B.Value: 1.0 [%] PumpModule.Pump.Curve: 5 9.000 [min] PumpModule.Pump.Flow.Nominal: 0.500 [ml/min] PumpModule.Pump.%B.Value: 95.0 [%] PumpModule.Pump.Curve: 5 10.000 [min] PumpModule.Pump.Flow.Nominal: 0.500 [ml/min] PumpModule.Pump.%B.Value: 95.0 [%] PumpModule.Pump.Curve: 5 10.500 [min] PumpModule.Pump.Flow.Nominal: 0.500 [ml/min] PumpModule.Pump.%B.Value: 1.0 [%] PumpModule.Pump.Curve: 5 15.000 [min] PumpModule.Pump.Flow.Nominal: 0.500 [ml/min] PumpModule.Pump.%B.Value: 1.0 [%] PumpModule.Pump.Curve: 5 15.000 [min] Stop Run
Flow Rate:	0.5 ml/min
Solvent A:	10mM Ammonium Formate in 95% ACN w/ .1% formic acid
Solvent B:	10mM Ammonium Formate in 50% ACN w/ .1% formic acid
Chromatography Type:	HILIC

MS:

MS ID:	MS003715
Analysis ID:	AN003981
Instrument Name:	Thermo Q Exactive Orbitrap
Instrument Type:	Orbitrap
MS Type:	ESI
MS Comments:	The samples were run using a Q ExactiveTM mass spectrometer coupled to a heated electrospray ionization (HESI) source. The spray voltage was set to 3.50 kV, capillary temperature to 350°C, sheath gas to 55, aux gas to 14, sweep gas to 4, and S-Lens RF Level to 30.0. The mass range was set to 67 – 1000 m/z, resolution 140,000 for full scan and 35,000 for ddMS2. AGC target was set to 1e6 for full scan and 2e5 for ddMS2. The max injection time (IT) was 100 seconds for full scan mode and 50 seconds for ddMS2. The number of microscans was 2, and normalized collision energy (NCE) was set to 20, 35, and 50. Samples were run in both positive and negative ion mode separately. The parameters for negative mode were the same except the spray voltage, which was set to 2.50 kV and capillary temperature to 380°C. Metabolites were identified from their Thermo.RAW scans using Compound DiscovererTM 3.3 software. Extraction blanks were used to determine and correct for reagent effects, allow for the creation of exclusions lists, mark background components, and filters the background components from the results table in Compound DiscovererTM 3.3. Pooled QCs were used for initial compound normalization and identification. All non-identified compounds were removed.
Ion Mode:	POSITIVE

MS ID:	MS003716
Analysis ID:	AN003982
Instrument Name:	Thermo Q Exactive Orbitrap
Instrument Type:	Orbitrap
MS Type:	ESI
MS Comments:	The samples were run using a Q ExactiveTM mass spectrometer coupled to a heated electrospray ionization (HESI) source. The spray voltage was set to 3.50 kV, capillary temperature to 350°C, sheath gas to 55, aux gas to 14, sweep gas to 4, and S-Lens RF Level to 30.0. The mass range was set to 67 – 1000 m/z, resolution 140,000 for full scan and 35,000 for ddMS2. AGC target was set to 1e6 for full scan and 2e5 for ddMS2. The max injection time (IT) was 100 seconds for full scan mode and 50 seconds for ddMS2. The number of microscans was 2, and normalized collision energy (NCE) was set to 20, 35, and 50. Samples were run in both positive and negative ion mode separately. The parameters for negative mode were the same except the spray voltage, which was set to 2.50 kV and capillary temperature to 380°C. Metabolites were identified from their Thermo.RAW scans using Compound DiscovererTM 3.3 software. Extraction blanks were used to determine and correct for reagent effects, allow for the creation of exclusions lists, mark background components, and filters the background components from the results table in Compound DiscovererTM 3.3. Pooled QCs were used for initial compound normalization and identification. All non-identified compounds were removed.
Ion Mode:	NEGATIVE